ICUSeaStar Medical Holding Corp

Nasdaq N/A


$ 0.22 $ -0.13 (-37.85 %)    

Thursday, 06-Jun-2024 15:59:52 EDT
QQQ $ 463.32 $ -0.36 (-0.08 %)
DIA $ 389.27 $ 0.74 (0.19 %)
SPY $ 534.63 $ -0.04 (-0.01 %)
TLT $ 93.23 $ -0.12 (-0.13 %)
GLD $ 219.44 $ 1.62 (0.74 %)
$ 0.354
$ 0.29
$ 0.21 x 600
$ 0.00 x 0
$ 0.20 - $ 0.30
$ 0.16 - $ 1.72
1,159,576
na
23.76M
$ 0.44
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 04-16-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-30-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-16-2022 06-30-2022 10-Q
9 05-19-2022 03-31-2022 10-Q
10 04-06-2022 12-31-2021 10-K
11 11-17-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-24-2021 03-31-2021 10-Q
14 03-31-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 seastar-medical-holdings-publishes-manuscript-on-multiorgan-failure-patients-treated-with-selective-cytopheretic-device

SCD's ability to improve clinical status of four critically ill pediatric and adult patients across multiple clinical condi...

 seastar-medical-holding-q1-2024-adj-eps-019-misses-015-estimate

SeaStar Medical Holding (NASDAQ:ICU) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate...

 why-alcoa-shares-are-trading-higher-here-are-20-stocks-moving-premarket

Shares of Alcoa Corporation (NYSE: AA) rose sharply in today’s pre-market trading after the company reported better-than-expec...

 seastar-medical-holding-q4-eps-019-misses-013-estimate

SeaStar Medical Holding (NASDAQ:ICU) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate...

 seastar-medical-provides-updates-on-enrollment-of-adult-pivotal-clinical-study-and-commercial-launch-of-quelimmune-fda-approved-in-pediatric-patients

Company plans to hold a business update conference call in AprilDENVER, March 12, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Hold...

 manuscript-discussing-the-benefit-of-seastar-medicals-selective-cytopheretic-device-in-patients-with-heart-failure-and-hyperinflammation-published-in-european-journal-of-heart-failure

Interest continues to grow in developing new strategies to reduce systemic inflammation as a means of improving outcomes in hea...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION